Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4693-4701

  Blask, David E ^a   Sauer, Leonard A ^a   Dauchy, Robert T ^a   Holowachuk, Eugene W ^a   Ruhoff, Mary S ^a   Kopff, Heather S ^a  

^a BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; CARRIER PROTEIN; CORIOLIC ACID; CYCLIC AMP; FORSKOLIN; HORMONE ANTAGONIST; LINOLEIC ACID; MELATONIN; MELATONIN RECEPTOR; MESSENGER RNA; PERTUSSIS TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FATTY ACID TRANSPORT; HORMONE BLOOD LEVEL; LIGHT DARK CYCLE; MALE; MITOSIS INHIBITION; MOLECULAR DYNAMICS; NONHUMAN; PINEALECTOMY; PRIORITY JOURNAL; RAT; RNA ANALYSIS; SIGNAL TRANSDUCTION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; BIOLOGICAL TRANSPORT; CELL DIVISION; CIRCADIAN RHYTHM; FORSKOLIN; LINOLEIC ACID; LINOLEIC ACIDS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MELATONIN; MODELS, BIOLOGICAL; NAPHTHALENES; PERFUSION; PERTUSSIS TOXIN; RATS; RATS, INBRED BUF; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION; VIRULENCE FACTORS, BORDETELLA;

EID: 0033567891     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Committee on Diet, Nutrition and Cancer - National Research Council, pp. 73-105. Washington, DC: National Academy Press, 1982.
2. Klurfield, D. M. Fat effects on experimental tumorigenesis. J. Nutr. Biochem., 6: 201-205, 1995.
3. Sauer, L. A., Nagel, W. O., Dauchy, R. T., Miceli, L. A., and Austin, J. E. Stimulation of tumor growth in adult rats in vivo during an acute fast. Cancer Res., 46: 3469-3475, 1986.
4. Sauer, L. A., and Dauchy, R. T. Stimulation of tumor growth in vivo during acute streptozotocin-induced diabetes. Cancer Res., 47: 1756-1761, 1987.
5. 3H]thymidine incorporation in hepatoma 7288CTC perfused in situ. Cancer Res., 48: 3106-3111, 1988.
6. Sauer, L. A., and Dauchy, R. T. Uptake of plasma lipids by tissue-isolated hepatomas 7288CTC and 7777 in vivo. Br. J. Cancer, 66: 290-296, 1992.
7. 3H)thymidine incorporation in hepatoma 7288CTC perfused in situ. Br. J. Cancer, 66: 297-303, 1992.
8. Sauer, L. A., Dauchy, R. T., and Blask, D. E. Dietary linoleic acid intake controls the arterial blood plasma concentration and the rates of growth and linoleic acid uptake and metabolism in hepatoma 7288CTC in Buffalo rats. J. Nutr., 127: 1412-1421, 1997.
9. Sauer, L. A., Dauchy, R. T., Blask, D. E., Armstrong, B. J., and Scalici, S. 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo. Cancer Res., 59: 4688-4692, 1999.
10. Glasgow, W. C., Hill, E. M., McGown, S. R., Tomer, K. B., and Eling, T. E. Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase. Mol. Pharmacol., 49: 1042-1048, 1996.
11. Glasgow, W. C., Hui, R., Everhart, A. L., Jayawickreme, S. P., Angerman-Stewart, J., Han, B-B., and Eling, T. E. The linoleic acid metabolite, (13S)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. J. Biol. Chem., 272: 19269-19276, 1997.
12. Mani, I., Iversen, L., and Ziboh, V. A. Upregulation of nuclear PKC and MAP-kinase during hypetproliferation of guinea pig epidermis: modulation by 13-(S)-hydroxyoctadecadienoic acid. Cell. Signalling, 10: 143-149, 1998.
13. Reiter, R. J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev., 12: 151-180, 1991.
14. Reiter, R. J. Melatonin: a multifaceted messenger to the masses. Lab. Med., 25: 438-441, 1994.
15. Maestroni, G. J. M., and Conti, A. Melatonin in relation to the immune system. In: H-S. Yu and R. J. Reiter (eds.), Melatonin: Biosynthesis, Physiological Effects, and Clinical Implications, pp. 289-310. Boca Raton, FL: CRC Press, 1993.
16. Blask, D. E. Melatonin in oncology. In: H-S. Yu and R. J. Reiter (eds.), Melatonin: Biosynthesis, Physiological Effects, and Clinical Implications, pp. 447-475. Boca Raton, FL: CRC Press, 1993.
17. Bartsch, H., and Bartsch, C. Effect of melatonin on experimental tumors under different pholoperiods and times of administration. J. Neural Transm., 52: 269-279, 1981.
18. Tamarkin, L., Cohen, M., Roselle, D., Reichter, C., Lippman, M., and Chamber, B. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res., 41: 4432-4436, 1981.
19. Shah, P. N., Mhatre, M. C., and Kothari, L. S. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res., 44: 3403-3407, 1984.
20. Blask, D. E., Pelletier, D. B., Hill, S. M., Lemus-Wilson, A., Grosso, D. S., Wilson, S. T., and Wise, M. E. Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo. J. Cancer Res. Clin. Oncol., 117: 526-532, 1991.
21. Panzer, A., and Viljoen, M. Validity of melatonin as an oncostatic agent. J. Pineal Res., 22: 184-202, 1997.
22. Ying, S. W., Niles, L. P., and Cracker, C. Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur. J. Pharmacol., 246: 89-96, 1993.
23. Molis, T., Spriggs, L. L., and Hill, S. M. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol. Endocrinol., 8: 1681-1690, 1994.
24. Molis, T., Spriggs, L. L., Jupiter, Y., and Hill, S. M. Melatonin modulation of estrogen-regulated proteins, growth factors, and protooncogenes in human breast cancer. J. Pineal Res., 18: 93-103, 1995.
25. Blask, D. E., Wilson, S. T., and Zalatan, F. Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway. Cancer Res., 57: 1909-1914, 1997.
26. Vaughan, M. K., and Vaughan, G. M. Metabolic and thyroidal consequences of melatonin administration in mammals. In: H-S. Yu and R. J. Reiter (eds.), Melatonin: Biosynthesis, Physiological Effects, and Clinical Implications, pp. 311-347. Boca Raton, FL: CRC Press, 1993.
27. Blask, D. E., Hill, S. M., Orslead, K. M., and Massa, J. S. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene (DMBA)-induced mammary tumorigenesis. J. Neural Transm., 67: 125-128, 1986.
28. Dauchy, R. T., Sauer, L. A., Blask, D. E., and Vaughan, G. M. Light contamination during the dark phase in "photoperiodically controlled" animal rooms: effect on tumor growth and metabolism in rats. Lab. Anim. Sci., 47: 511-518, 1997.
29. Reppert, S. M., and Weaver, D. R. Melatonin madness. Cell, 83: 1059-1062, 1995.
30. Grota, L. J., Snieckus, V., DeSilva, S. O., Tsui, H. W., Holloway, W. R., Lewy, A. J., and Brown, G. M. Radioimmunoassay of melatonin in rat serum. Prog. Neuropsychopharmacol., 5: 523-526, 1981.
31. Hoffman, R. A., and Reiter, R. J. Rapid pinealectomy in hamsters and other small rodents. Anat. Rec., 153: 19-22, 1965.
32. Vaughan, G. M. New sensitive serum melatonin radioimmunoassay employing the Kennaway G280 antibody: Syrian hamster morning adrenergic response. J. Pineal Res., 15: 88-103, 1993.
33. Holowachuk, E. W., and Ruhoff, M. S. Biologically active recombinant rat granulocyte macrophage colony stimulating factor produced in Escherichia coli. Prot. Express. Purif., 6: 588-596, 1995.
34. Schaffer, J. E., and Lodish, H. F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell, 79: 427-436, 1994.
35. Fitscher, B. A., Elsing, C., Riedel, H. D., Gorski, J., and Stremmel, W. Protein-mediated facilitated uptake processes for fatty acids, bilirubin, and other amphiphatic compounds. Proc. Soc. Exp. Biol. Med., 212: 15-23, 1996.
36. Folch, J., Lees, M., and Sloane-Stanley, G. H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226: 497-507, 1957.
37. DeRubertis, F. R., and Craven, P. A. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP. Metabolism, 25: 1611-1625, 1976.
38. Cho-Chung, Y. S. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res., 50: 7093-7100, 1990.
39. Reppert, S. M., Weaver, D. R., and Ebisawa, T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron., 13: 1177-1185, 1994.
40. Guardiola-Lemaitre, B., and Delagrange, P. Melatonin agonists and antagonists: pharmacological tools or therapeutic agents? In: S. M. Webb, M. Puig-Domingo, M. Moller, and P. Pevet (eds.), Pineal Update, pp. 301-319. Westbury: PJD Publications, 1997.
41. Takahashi, K. Inoue, K., and Takahashi, Y. No effect of pinealectomy on the parallel shift in circadian rhythms of adrenocortical activity and food intake in blinded rats. Endocr. Jap., 23: 417-421, 1976.
42. +-dependent malic enzyme activity and malate-dependent pyruvate formation are progression-linked in Morris hepatomas. J. Biol. Chem., 255: 3844-3848, 1980.
43. Fenselau, A., Wallis, K., and Morris, H. P. Subcellular localization of acetoacetate coenzyme A transferase in rat hepatomas. Cancer Res., 36: 4429-4433, 1976.
44. Ram, P., Kiefer, T., Silverman, M., Song, Y., Brown, G. M., and Hill, S. M. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol. Cell. Endocrinol., 141: 53-64, 1998.
45. Cos, S., and Blask, D. E. Melatonin modulates growth factor activity in MCF-7 human breast cancer cells. J. Pineal Res., 17: 25-32, 1994.
46. Lemus-Wilson, A., Kelly, P. A., and Blask, D. E. Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture. Br. J. Cancer, 72: 1435-1440, 1995.
47. Yu, H-S., Hernandez, V., Haywood, M., and Wong, C. G. Melatonin inhibits the proliferation of retinal pigment epithelial (RPE) cells in vitro. In Vitro Cell Dev. Biol., 29A: 415-418, 1993.
48. Hu, C. S. T., Forrante, A., Schmidt, S., Rathjen, D. A., Robinson, B. S., Poulos, A., and Murray, A. W. Inhibition of gap junctional communication by polyunsaturated fatty acids in WB cells: evidence that connexin 43 is not hyperphosphorylated. Carcinogenesis (Lond.), 16: 1505-1511, 1995.
49. Hayashi, T., Matesic, D. F., Nomata, K., Kang, K-S., Chang, C-C., and Trosko, J. E. Stimulation of cell proliferation and inhibition of gap junctional intercellular communication by linoleic acid. Cancer Lett., 112:103-111, 1997.
50. Kojima, T., Mochizuki, C., Mitaka, T., and Mochizuki, Y. Effects of melatonin on proliferation, oxidative stress and Cx32 gap junction protein expression in primary cultures of adult rat hepatocytes. Cell. Struct. Funct., 22: 347-356, 1997.
51. Ubeda, A., Trillo, M. A., House, D. E., and Blackman, C. F. Melatonin enhances junctional transfer in normal C3H/10T1/2 cells. Cancer Lett., 91: 241-245, 1995.
52. Reiter, R. J., Tan, D. X., Poeggler, B., Menendez-Pelaez, L. D., Chen, S., and Saarela, S. Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann N. Y. Acad. Sci., 719: 1-12, 1994.
53. Reiter, R. J., Carneiro, R. C., and Oh, C. S. Melatonin in relation to cellular antioxdiative defense mechanisms. Horm. Metab. Res., 29: 363-372, 1997.
54. Gennari, L., Doci, R., and Bozzetti, F. Liver tumors. In: M. Peckham, H. Pinedo, and V. Veronesi (eds.), Oxford Textbook of Oncology, pp. 1201-1220. Oxford: Oxford University Press, 1995.